ArticleCureus2025
Potassium Sodium Hydrogen Citrate in Managing Surgical Candidates With Urinary Stones: A Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney stone disease is highly prevalent in Saudi Arabia, where conventional treatments often involve invasive procedures that carry significant risks. This case series examines the efficacy of potassium sodium hydrogen citrate as a non-invasive alternative for managing kidney stones. Five patients with complex medical histories, large stone sizes, and diverse stone compositions were treated with this therapy, resulting in complete stone dissolution without the need for surgical intervention. The findings highlight the potential of this approach to effectively dissolve stones and prevent recurrence, particularly for patients deemed unsuitable for surgery. Despite its proven efficacy, the adoption of chemical management remains underutilized in Saudi Arabia. Incorporating potassium sodium hydrogen citrate into the standard treatment protocols could reduce dependence on invasive procedures, improve patient outcomes, and alleviate the burden on healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.